SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
黎初阳
Lv3
270 积分
2021-03-04 加入
最近求助
最近应助
互助留言
Olezarsen for Hypertriglyceridemia in Patients at High Cardiovascular Risk
12天前
已完结
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
26天前
已完结
Assessment of efficacy and safety of volanesorsen for treatment of metabolic complications in patients with familial partial lipodystrophy: Results of the BROADEN study
1个月前
已完结
ANGPTL3 and Apolipoprotein C-III as Novel Lipid-Lowering Targets
1个月前
已完结
At ObesityWeek, More Data and Questions About Semaglutide, Tirzepatide, and Retatrutide
2个月前
已完结
An innovative antibody fusion protein targeting PD-L1, VEGF and TGF-β with enhanced antitumor efficacies
2个月前
已完结
Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer
3个月前
已完结
Population Pharmacokinetic Modeling of Cotadutide: A Dual Agonist Peptide of Glucagon-Like Peptide and Glucagon Receptors Administered to Participants with Type II Diabetes Mellitus, Chronic Kidney Disease, Obesity and Non-Alcoholic Steatohepatitis
3个月前
已完结
Population Pharmacokinetic Modeling of Cotadutide: A Dual Agonist Peptide of Glucagon-Like Peptide and Glucagon Receptors Administered to Participants with Type II Diabetes Mellitus, Chronic Kidney Disease, Obesity and Non-Alcoholic Steatohepatitis
3个月前
已关闭
FGF21-based pharmacotherapy – potential utility for metabolic disorders
4个月前
已完结
没有进行任何应助
重新发布【积分已退回】
3个月前
已经找到【积分已退回】
10个月前
感谢
1年前
感谢
1年前
谢谢
1年前
感谢
1年前
感谢,正确。
2年前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论